The United Arab Emirates has begun recalling infant formula from a well-known international brand amid global food safety concerns. The recall was announced late Wednesday by the Emirates Drug Establishment (EDE), which emphasized that the move is voluntary and precautionary in nature.
The products affected include five infant formula variants intended for newborns. The recall follows the detection of trace amounts of Bacillus cereus in one of the raw materials used in the formula. This bacterium can, in certain cases, produce a toxin called cereulide, which may pose health risks to infants if consumed in sufficient amounts.
The company had previously recalled certain batches of its products in Europe, followed by similar recalls in Africa, Asia, and the United States.
At least 37 countries, including Australia, Brazil, China, Mexico, and South Africa, have issued warnings regarding potential contamination. In the Gulf region, Saudi Arabia, Kuwait, and Qatar have also banned the sale of this brand’s infant formula.
Experts advise parents to monitor infants for symptoms such as severe or persistent vomiting, diarrhea, or unusual lethargy after consuming the formula.
Immediate medical attention is recommended if these symptoms appear. If no symptoms occur within 30 minutes to six hours, there is generally no cause for panic, though consulting a paediatrician is advised in any emergency.
The EDE and health authorities have confirmed that no illness or adverse effects linked to this infant formula have been reported in the UAE so far. Authorities are closely monitoring the situation to ensure public safety.
The recall highlights the importance of vigilance in infant nutrition and demonstrates proactive measures by the UAE to protect newborns. Parents are urged to check product batches and follow official guidance to ensure the safety and well-being of their children.
